Today: 11 June 2026
Browse Category

NYSE:GPA 6 January 2026

Brazil stock market today: Oil shock, Ibovespa reshuffle and a CEO switch to watch before the B3 bell

Brazil stock market today: Oil shock, Ibovespa reshuffle and a CEO switch to watch before the B3 bell

The Ibovespa closed up 0.83% at 161,869.76 on Monday, led by gains in Vale and banks, while Petrobras fell despite a jump in oil prices after U.S. moves on Venezuela. Trading volume reached R$24.9 billion. The dollar slipped to near R$5.40. Investors are watching the new Ibovespa portfolio and executive changes at GPA and IMC ahead of Brazil’s inflation data on Jan. 9.
6 January 2026
··

Stock Market Today

  • Top Software Stocks Set for Rally in Second Half, Says BofA
    June 11, 2026, 11:15 AM EDT. Bank of America (BofA) has identified leading software stocks poised for a significant rally in the second half of the year. While specific companies were not detailed, BofA's outlook highlights growth potential in the tech sector amid evolving market conditions. Investors are closely watching software firms as demand for digital solutions continues to expand, driven by cloud computing and enterprise software trends. This bullish stance from a major financial institution underscores confidence in software stocks as key components of portfolio growth strategies moving forward.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Go toTop